Education
About Us
Working with TipRanks
Follow Us
BBIN - ETF AI Analysis
Top Page
JPMorgan BetaBuilders International Equity ETF (BBIN)
Rating:67Neutral
Price Target:―
Positive Factors
Low Expense Ratio
The fund charges a relatively low fee, which helps investors keep more of their returns over time.
Broad International Diversification
Holdings spread across many countries such as Japan, the UK, and several European markets help reduce the impact of weakness in any single market.
Supportive Recent Performance
The ETF has shown positive performance over the past month, three months, and year to date, indicating generally favorable recent momentum.
Negative Factors
Heavy Exposure to Financials and Industrials
A large share of the portfolio is in financial and industrial companies, which can hurt returns if these sectors face a downturn.
Mixed Results Among Top Holdings
Some major positions, such as Nestlé, SAP, and Shell, have shown weaker year-to-date performance, which can drag on the fund’s overall results.
Limited U.S. Market Exposure
With only a small portion invested in U.S. companies, the fund may lag if U.S. stocks outperform other global markets.
BBIN vs. SPDR S&P 500 ETF (SPY)
AUM6.06B
RegionDeveloped Markets
Expense Ratio0.07%
Beta0.72
IssuerJPMorgan
Inception DateDec 03, 2019
Dividend Yield3.76%
Asset ClassEquity
Index TrackedMorningstar Developed Markets ex-North America Target Market Exposure Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume304,113
30 Day Avg. Volume226,751
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
85.19Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering637
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
BBIN Summary
BBIN is the JPMorgan BetaBuilders International Equity ETF, which tracks the Morningstar Developed Markets ex-North America Index. It invests in a wide range of companies outside the U.S., mainly in countries like Japan, the UK, and France. The fund holds many well-known names such as Toyota, Nestlé, and ASML, and spreads your money across sectors like financials, industrials, and healthcare. Someone might invest in BBIN to diversify beyond U.S. stocks and tap into long-term growth in developed international markets. A key risk is that its value can rise and fall with global stock markets and currency swings.
How much will it cost me?The JPMorgan BetaBuilders International Equity ETF (BBIN) has an expense ratio of 0.07%, meaning you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically has lower costs than actively managed funds.
What would affect this ETF?Positive drivers for BBIN could include economic growth in developed markets outside North America, which may boost the performance of its top holdings like ASML, Nestlé, and Toyota. However, negative factors such as rising interest rates or geopolitical tensions in Europe or Asia could impact sectors like Financials and Industrials, which have significant weight in the ETF. Additionally, regulatory changes in these regions could affect the profitability of key companies in the portfolio.
BBIN Top 10 Holdings
BBIN leans heavily on a mix of European and Asian blue chips, with no single stock dominating, but a few clear leaders setting the tone. ASML has been a powerful engine for returns, riding strong momentum in chip equipment. Big pharma names like Roche, AstraZeneca, and Novartis are also rising, giving the fund a healthy dose of defensive growth. On the financial side, HSBC, Mitsubishi UFJ, and Commonwealth Bank are steadily helping, not hurting. With holdings spread across developed markets outside North America, this is a truly international play, not a U.S.-centric story.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.60% | $157.04M | €438.37B | 79.71% | 76 Outperform | |
| Roche Holding AG | 1.49% | $90.06M | CHF265.95B | 26.90% | 73 Outperform | |
| AstraZeneca | 1.48% | $89.68M | $300.78B | 22.44% | 80 Outperform | |
| Novartis AG | 1.44% | $87.26M | CHF238.47B | 21.58% | 80 Outperform | |
| HSBC Holdings | 1.43% | $86.27M | £214.86B | 45.65% | 80 Outperform | |
| Nestlé SA | 1.28% | $77.13M | CHF202.47B | 0.44% | 71 Outperform | |
| Toyota Motor | 1.23% | $74.28M | ¥44.22T | 23.81% | 80 Outperform | |
| Shell (UK) | 1.16% | $70.21M | £180.69B | 21.76% | 73 Outperform | |
| SAP SE | 1.00% | $60.47M | €195.70B | -30.22% | 66 Neutral | |
| Commonwealth Bank of Australia | 0.97% | $58.93M | AU$283.29B | 16.14% | 64 Neutral |
BBIN Technical Analysis
Neutral
―
Price Trends
76.28
Negative
73.28
Positive
69.96
Positive
Market Momentum
-0.27
Positive
39.16
Neutral
19.28
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BBIN, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 78.23, equal to the 50-day MA of 76.28, and equal to the 200-day MA of 69.96, indicating a neutral trend. The MACD of -0.27 indicates Positive momentum. The RSI at 39.16 is Neutral, neither overbought nor oversold. The STOCH value of 19.28 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for BBIN.
BBIN Peer Comparison
Comparison Results
Performance Comparison
BBIN
JPMorgan BetaBuilders International Equity ETF
74.97
15.20
25.43%
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
DBEF
Xtrackers MSCI EAFE Hedged Equity ETF
―
―
―
FENI
Fidelity Enhanced International ETF
―
―
―
EFAV
iShares MSCI EAFE Min Vol Factor ETF
―
―
―
IHDG
WisdomTree International Hedged Quality Dividend Growth Fund
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents